# ACR | LAB Urine Analysis Test System Evaluation of Performance

Study · id `cardio:ct-nct04466501` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04466501](<https://clinicaltrials.gov/study/NCT04466501>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04466501

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 375 participants.

## Technical summary

Registry record NCT04466501. Allocation not applicable; no masking; primary purpose diagnostic. Start 2019-06-30 (actual); primary completion 2019-09-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 375 participants (enrolled count; ClinicalTrials.gov record NCT04466501, source copy `cardio:ctgov-nct04466501-2020-07-10`, retrieved 2026-10-26)
- Started: 2019-06-30 (actual) (ClinicalTrials.gov record NCT04466501, source copy `cardio:ctgov-nct04466501-2020-07-10`, retrieved 2026-10-26)
- Primary completion: 2019-09-30 (actual) (ClinicalTrials.gov record NCT04466501, source copy `cardio:ctgov-nct04466501-2020-07-10`, retrieved 2026-10-26)
- Completion: 2019-09-30 (actual) (ClinicalTrials.gov record NCT04466501, source copy `cardio:ctgov-nct04466501-2020-07-10`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04466501, source copy `cardio:ctgov-nct04466501-2020-07-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04466501-2020-07-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: ACR | LAB Urine Analysis Test System Evaluation of Performance
- Condition: Diabetes
- Condition: Hypertension
- Intervention (Device): ACR LAB
- Lead sponsor: Healthy.io Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: 71da0f24e72e5e74cf6db9efa1684406a56e25d60838db378a4f8773e7b41f0c
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
